India's pharmaceutical landscape presents a complex picture, largely shaped by the considerable influence of a few dominant players. While the sector is often lauded for its generic drug manufacturing capabilities, a closer examination reveals a degree of sector concentration that warrants scrutiny. These incumbent companies, including organization